hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 18:43:30 - browse：677

Andrea Coravos, managing director at ICON, speaks at the STAT Breakthrough Summit West in San Francisco Thursday as Ida Sim, chief research informatics officer at UCSF, looks on. Sarah Gonzalez for STAT

Just because the Food and Drug Administration has given the Apple Watch and other wearable devices the OK to market the health benefits of their tracking and algorithms doesn’t mean that the data they generate are useful for either patients or their doctors, experts said Thursday at the STAT Breakthrough Summit West in San Francisco.

“Yesterday, I saw a patient with type 2 diabetes who has a continuous glucose monitor, and so she’s been tracking her blood sugar every five minutes,” said Ida Sim, a primary care physician and chief research informatics officer at the University of California, San Francisco. “[I] sat with her for almost an hour yesterday. I couldn’t get to her CGM data — she had it on her phone, but the report goes into a website that I didn’t have the login to, and it hadn’t been downloaded into my electronic medical record. So all this tracking data, I didn’t have it.”

Not only do clinicians not have the ability to access data that their patients want to use to guide their care, but primary care doctors often don’t know how to interpret that firehose of data, said Sim. She asked some of her endocrinology research colleagues how they use that data and they explained the calculations needed to create biomarker metrics from them. That made the data largely useless to her as a doctor, and it was frustrating.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： iTeos Therapeutics debuts first data on TIGIT

entertainment

focus

WSS

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Adam's Biotech Scorecard: Do Sarepta's exon

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Readout Newsletter: CAR

Scientists successfully use ultrasound imaging to map brain activity

knowledge

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Sports medicine is finally prioritizing gender equality

Amid AI frenzy, a top HHS official's quest to create safeguards

Supreme Court strikes down use of affirmative action

Ebola: Gilead Sciences antiviral shows promise as new treatment

In age of alternative facts, a scholarly course on calling out crap

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Malaria cases in Florida and Texas: Here’s what you need to know

Antibiotic resistance nearly killed me, so I'm raising awareness of it

leisure time

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Ebola: Gilead Sciences antiviral shows promise as new treatment

Heat waves linked to early deliveries, preterm births in new study

First Opinion Podcast: What happens when kids become caregivers?

Addiction doctors spar with methadone clinics over legislation

Pushing for an NIH office for post

hotspot

entertainment

focus

focus